BIC (BB) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
18 Nov, 2025Opening remarks and agenda
Outgoing Chair and CEO expressed gratitude to board members and management, highlighting leadership transitions and welcoming new directors.
The meeting was chaired by Candace Matthews, with translation provided, and was broadcast live and available for replay.
Meeting opened with legal statement by Director of Corporate, Securities and M&A.
The agenda, approved by the board, included financial results, strategic updates, governance, voting on resolutions, 2024 highlights, 2025 outlook, supply chain, people and culture, Horizon Plan, and Tangle Teezer.
Financial performance review
2024 net sales reached €2,197m, up 3.1% like-for-like, with adjusted operating margin at 15.6%, up 90 basis points.
Adjusted earnings per share rose to EUR 6.15, marking the fifth consecutive annual increase.
Free cash flow before acquisitions/disposals was €271m; net cash position at €189m; Tangle Teezer acquisition completed for €201m.
Q1 2025 net sales were €478m, down 7% like-for-like, but Tangle Teezer showed double-digit growth.
Blade Excellence division contributed 25% of group net sales, with 5.0% growth and 18.5% EBIT margin.
Dividend announcements
Proposed ordinary dividend of €3.08 per share for 2024, an 8% increase over 2023, representing 50% payout of adjusted EPS, payable June 2025.
Share buyback program renewed for up to €40m in 2025.
Latest events from BIC
- Net sales fell 0.9% to €2,090m, but Tangle Teezer and cash flow guidance remain positive for 2026.BB
Q4 202525 Feb 2026 - 2024 sales hit €2.2bn, with strong margins, cash flow, and leadership in core categories.BB
Investor presentation24 Feb 2026 - Resilient margins and growth outside North America support 2024 outlook and cash flow.BB
Q2 20242 Feb 2026 - Q3 2024 saw robust margin gains and cash flow, with an upgraded EBIT margin outlook.BB
Q3 202418 Jan 2026 - Resilient 2024 results with strong margins and Tangle Teezer set to drive 2025 growth.BB
Q4 202428 Dec 2025 - Q1 2025 sales fell 8.3% as reported; 2025 outlook cut to 0–3% growth, 15% EBIT margin.BB
Q1 202526 Dec 2025 - Q2 growth and Tangle Teezer gains offset H1 sales decline, with margins and outlook resilient.BB
Q2 20253 Nov 2025 - 2025 outlook cut after soft Q3, tariff impacts, and Cello divestiture; Tangle Teezer outperformed.BB
Q3 202529 Oct 2025 - Resilient 2024 performance with strong cash flow, innovation, and sustainability focus.BB
Investor Presentation30 Jul 2025